DE69219602D1 - Pyrazolopyrimidin- und pyrimidinylbisphosphonsäureester als entzündungshemmende mittel - Google Patents

Pyrazolopyrimidin- und pyrimidinylbisphosphonsäureester als entzündungshemmende mittel

Info

Publication number
DE69219602D1
DE69219602D1 DE69219602T DE69219602T DE69219602D1 DE 69219602 D1 DE69219602 D1 DE 69219602D1 DE 69219602 T DE69219602 T DE 69219602T DE 69219602 T DE69219602 T DE 69219602T DE 69219602 D1 DE69219602 D1 DE 69219602D1
Authority
DE
Germany
Prior art keywords
agents
pyrimidinylbisphosphonic
flamming
pyrazolopyrimidine
acid esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69219602T
Other languages
German (de)
English (en)
Inventor
Richard Nugent
Stephen Schlachter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE69219602D1 publication Critical patent/DE69219602D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69219602T 1991-07-03 1992-07-01 Pyrazolopyrimidin- und pyrimidinylbisphosphonsäureester als entzündungshemmende mittel Expired - Lifetime DE69219602D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72504791A 1991-07-03 1991-07-03
US72504691A 1991-07-03 1991-07-03
PCT/US1992/005398 WO1993001198A1 (en) 1991-07-03 1992-07-01 Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories

Publications (1)

Publication Number Publication Date
DE69219602D1 true DE69219602D1 (de) 1997-06-12

Family

ID=27111084

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69219602T Expired - Lifetime DE69219602D1 (de) 1991-07-03 1992-07-01 Pyrazolopyrimidin- und pyrimidinylbisphosphonsäureester als entzündungshemmende mittel

Country Status (19)

Country Link
US (1) US5397774A (enExample)
EP (2) EP0521622B1 (enExample)
JP (1) JPH06509100A (enExample)
CN (1) CN1031826C (enExample)
AT (1) ATE152728T1 (enExample)
AU (1) AU653428B2 (enExample)
CA (1) CA2110167A1 (enExample)
CZ (1) CZ19595A3 (enExample)
DE (1) DE69219602D1 (enExample)
FI (1) FI935944A0 (enExample)
HU (2) HUT70758A (enExample)
IE (1) IE922162A1 (enExample)
IL (1) IL102171A (enExample)
MX (1) MX9203945A (enExample)
NO (1) NO940009L (enExample)
RU (1) RU2079506C1 (enExample)
SK (1) SK277986B6 (enExample)
TW (1) TW222638B (enExample)
WO (1) WO1993001198A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE157097T1 (de) * 1992-08-07 1997-09-15 Upjohn Co Phosphonoessigsäure und ester als antientzündungsmittel
EP0663919A1 (en) * 1992-10-09 1995-07-26 PHARMACIA & UPJOHN COMPANY Pyrimidine bisphosphonate esters as anti-inflamatories
EP0724573A1 (en) * 1993-10-20 1996-08-07 PHARMACIA & UPJOHN COMPANY Pyrimidinones as antiarthritic and anti-inflammatories
US5880111A (en) * 1995-06-07 1999-03-09 Farcasiu; Dan Therapeutic derivations of diphosphonates
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
IT1303672B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
US6579860B1 (en) * 1998-12-25 2003-06-17 Toray Industries, Inc. Interleukin-6 production inhibitors
AU4331500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
AU4203500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolopyrimidines as crf antagonists
US6630476B2 (en) 2000-07-07 2003-10-07 Bristol-Myers Squibb Pharma Company Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
RU2183610C1 (ru) * 2000-11-15 2002-06-20 Институт молекулярной генетики РАН Высокомеченный тритием n-[3-(3-цианопиразоло[1,5-а]пиримидин-7-ил)фенил]-n-этилацетамид
AU783516B2 (en) 2001-04-30 2005-11-03 Warner-Lambert Company Methods, kits and compositions for using pyrrole derivatives
EP1926734A1 (en) 2005-08-22 2008-06-04 Amgen Inc. Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
EP2270021A1 (en) 2009-06-18 2011-01-05 Centre National de la Recherche Scientifique Phosphonates synthons for the synthesis of phosphonates derivatives showing better bioavailability
EP2767543B1 (en) * 2011-10-14 2017-08-30 Aktsionernoe Obshcestvo "Proizvodstvenno-Kommercheskaya Assotsiatsiya AZT" Salts of carbamoyl phosphonic acid esters which act as selective inhibitors of human immunodeficiency virus hiv-1 production
EP3187492A4 (en) * 2014-08-29 2018-05-09 The University of Tokyo Pyrimidinone derivative having autotaxin-inhibitory activity
US10183949B2 (en) 2014-08-29 2019-01-22 The University Of Tokyo Pyrimidinone derivative having autotaxin-inhibitory activity
FI4081511T6 (fi) 2019-12-23 2026-06-09 Sitryx Therapeutics Ltd Karboksijohdannaisia, joilla on anti-inflammatorisia ominaisuuksia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
DE2703712A1 (de) * 1977-01-29 1978-08-03 Bayer Ag Substituierte pyrimidinon eckige klammer auf (di)-thio eckige klammer zu -phosphor-(phosphon)-saeureester bzw. -esteramide, verfahren zu ihrer herstellung und ihre verwendung als insektizide, akarizide und nematizide
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
PH27078A (en) * 1984-12-21 1993-02-01 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonates
DE3626058A1 (de) * 1986-08-01 1988-02-11 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
EP0272208B1 (de) * 1986-11-21 1991-06-12 Ciba-Geigy Ag Aromatisch substituierte Azacyclo-alkylalkandiphosphonsäuren
US5071840A (en) * 1986-12-19 1991-12-10 Norwich Eaton Pharmaceuticals, Inc. Certain heterocyclic substituted diphosphonate compounds pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
IL84731A0 (en) * 1986-12-19 1988-05-31 Norwich Eaton Pharma Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
DE3719513A1 (de) * 1987-06-11 1988-12-22 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4990503A (en) * 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives
AU4387893A (en) * 1992-07-16 1994-02-14 Upjohn Company, The Phosphono derivatives as antiinflammatory and antiarthritic agents
EP0663919A1 (en) * 1992-10-09 1995-07-26 PHARMACIA & UPJOHN COMPANY Pyrimidine bisphosphonate esters as anti-inflamatories

Also Published As

Publication number Publication date
IE922162A1 (en) 1993-01-13
MX9203945A (es) 1993-04-01
CZ19595A3 (en) 1995-10-18
RU2079506C1 (ru) 1997-05-20
EP0593575B1 (en) 1997-05-07
HU211488A9 (en) 1995-11-28
HU9400003D0 (en) 1994-05-30
NO940009L (no) 1994-01-09
EP0521622B1 (en) 1997-08-13
ATE152728T1 (de) 1997-05-15
JPH06509100A (ja) 1994-10-13
FI935944A7 (fi) 1993-12-30
CN1031826C (zh) 1996-05-22
CA2110167A1 (en) 1993-01-21
IL102171A0 (en) 1993-01-14
CN1068332A (zh) 1993-01-27
FI935944L (fi) 1993-12-30
US5397774A (en) 1995-03-14
FI935944A0 (fi) 1993-12-30
AU2240892A (en) 1993-02-11
SK150493A3 (en) 1994-11-09
EP0593575A1 (en) 1994-04-27
HUT70758A (en) 1995-10-30
IL102171A (en) 1996-11-14
TW222638B (enExample) 1994-04-21
AU653428B2 (en) 1994-09-29
SK277986B6 (en) 1995-09-13
EP0521622A1 (en) 1993-01-07
NO940009D0 (no) 1994-01-03
WO1993001198A1 (en) 1993-01-21

Similar Documents

Publication Publication Date Title
ATE152728T1 (de) Pyrazolopyrimidin- und pyrimidinylbisphosphonsäureester als entzündungshemmende mittel
ATE203026T1 (de) Hydroxymethyl-imidazodiazepine und deren ester
KR100344712B1 (ko) 알러지성및염증성질환의치료에유용한화합물
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
NO180718C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive mercaptoacetylamidderivater
EP0604641A4 (en) COMPOSITION CONTAINING AMINO DERIVATIVES OR RELATED TO BENZOIC ACID AMINES AND USES THEREOF, INCLUDING IN THE TREATMENT OF INFLAMMATORY DISEASES.
ATE67185T1 (de) Substituierte oxindol-3-carboxamine als entzuendungshemmendes und schmerzstillendes mittel.
DK0435321T3 (da) Nye A-nor-steroid-3-carboxylsyrederivater
DE69327572D1 (de) Phosphonsäurediester-derivat
DE69302883D1 (de) L-Carnitin- und Alkanoyl-L-Carnitin-Ester mit Glykolsäure oder ihre Ester und diese enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
DE69331171D1 (de) Chinolin und Chinazolin Derivate zur Behandlung von Arthritis
DE69212925D1 (de) Polymerisationsinhibitoren für Acrylsäure und Ester
ATE89556T1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
SE9100920D0 (sv) New active compounds
RU93058618A (ru) Пиразолопиримидин- и пиримидинилбисфосфоновые сложные эфиры, используемые в качестве противовоспалительных средств
DE69500511D1 (de) Phosphatdiester zur Behandlung von proliferativen Erkrankungen der Epidermis
DK0599114T3 (da) Vitamin D3-analoge
DK0602961T3 (da) Hudbehandlingssammensætning af lanolin/lanolinsyreestere
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
FR2687667B1 (fr) Esters d'acides carboxyliques d'hydroxyphenylalcanols comme stabilisants.
DE3773059D1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
HUP9902417A2 (hu) Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai
DE69527854D1 (de) Derivate substituierter amidinonaphthylester
DE59310343D1 (de) Desinfektionsmittel
ATE127806T1 (de) Antibiotikverbindungen und ihre herstellung.

Legal Events

Date Code Title Description
8332 No legal effect for de